T6	B-Entity	0	1	S	S	B-NP	NN	O	4	NMOD	O
T6	I-Entity	1	2	-	-	I-NP	HYPH	O	4	NMOD	O
T6	I-Entity	2	7	allyl	allyl	I-NP	NN	O	4	NMOD	O
T6	I-Entity	8	16	cysteine	cysteine	I-NP	NN	O	5	SUB	O
O	O	17	25	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	26	36	activation	activation	B-NP	NN	O	5	OBJ	O
O	O	37	39	of	of	B-PP	IN	O	6	NMOD	O
T7	B-Entity	40	47	nuclear	nuclear	B-NP	JJ	B-protein	11	NMOD	B-protein
T7	I-Entity	48	54	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T7	I-Entity	55	60	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T7	I-Entity	61	62	B	B	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	63	65	in	in	B-PP	IN	O	6	NMOD	O
O	O	66	71	human	human	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	72	73	T	T	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	74	79	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	79	80	.	.	O	.	O	5	P	O

O	O	82	90	Reactive	Reactive	B-NP	JJ	O	3	NMOD	O
O	O	91	97	oxygen	oxygen	I-NP	NN	O	3	NMOD	O
O	O	98	105	species	specie	I-NP	NNS	O	4	SUB	O
O	O	106	109	are	be	B-VP	VBP	O	0	ROOT	O
O	O	110	118	involved	involve	I-VP	VBN	O	4	VC	O
O	O	119	121	in	in	B-PP	IN	O	5	VMOD	O
O	O	122	128	signal	signal	B-NP	NN	O	9	NMOD	O
O	O	129	141	transduction	transduction	I-NP	NN	O	9	NMOD	O
O	O	142	150	pathways	pathway	I-NP	NNS	O	6	PMOD	O
O	O	151	158	leading	lead	B-VP	VBG	O	9	NMOD	O
O	O	159	161	to	to	B-PP	TO	O	10	VMOD	O
T8	B-Entity	162	169	nuclear	nuclear	B-NP	JJ	B-protein	15	NMOD	B-protein
T8	I-Entity	170	176	factor	factor	I-NP	NN	I-protein	15	NMOD	I-protein
T8	I-Entity	177	182	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T8	I-Entity	183	184	B	B	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	185	186	(	(	O	(	O	21	DEP	O
T9	B-Entity	186	188	NF	NF	B-NP	NN	B-protein	20	NMOD	B-protein
T9	I-Entity	188	189	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T9	I-Entity	189	194	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T9	I-Entity	195	196	B	B	I-NP	NN	I-protein	21	DEP	I-protein
O	O	196	197	)	)	O	)	O	15	NMOD	O
O	O	198	208	activation	activation	B-NP	NN	O	11	PMOD	O
O	O	209	214	which	which	B-NP	WDT	O	22	NMOD	O
O	O	215	218	has	have	B-VP	VBZ	O	23	SBAR	O
O	O	219	223	been	be	I-VP	VBN	O	24	VC	O
O	O	224	234	implicated	implicate	I-VP	VBN	O	25	VC	O
O	O	235	237	in	in	B-PP	IN	O	26	VMOD	O
O	O	238	241	the	the	B-NP	DT	O	29	NMOD	O
O	O	242	252	regulation	regulation	I-NP	NN	O	27	PMOD	O
O	O	253	255	of	of	B-PP	IN	O	29	NMOD	O
O	O	256	260	gene	gene	B-NP	NN	O	32	NMOD	O
O	O	261	274	transcription	transcription	I-NP	NN	O	30	PMOD	O
O	O	274	275	.	.	O	.	O	4	P	O

O	O	276	278	We	We	B-NP	PRP	O	3	SUB	O
O	O	279	287	recently	recently	B-ADVP	RB	O	3	VMOD	O
O	O	288	296	reported	report	B-VP	VBD	O	0	ROOT	O
O	O	297	301	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	302	303	a	a	B-NP	DT	O	7	NMOD	O
O	O	304	310	garlic	garlic	I-NP	NN	O	7	NMOD	O
O	O	311	319	compound	compound	I-NP	NN	O	12	NMOD	O
O	O	319	320	,	,	O	,	O	12	P	O
T10	B-Entity	321	322	S	S	B-NP	NN	O	12	NMOD	O
T10	I-Entity	322	323	-	-	O	HYPH	O	12	NMOD	O
T10	I-Entity	323	328	allyl	allyl	B-NP	NN	O	12	NMOD	O
T10	I-Entity	329	337	cysteine	cysteine	I-NP	NN	O	17	SUB	O
O	O	338	339	(	(	O	(	O	15	DEP	O
T11	B-Entity	339	342	SAC	SAC	B-NP	NN	O	15	DEP	O
O	O	342	343	)	)	O	)	O	12	NMOD	O
O	O	343	344	,	,	O	,	O	12	P	O
O	O	345	353	protects	protect	B-VP	VBZ	O	4	SBAR	O
O	O	354	360	bovine	bovine	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	361	370	pulmonary	pulmonary	I-NP	JJ	I-cell_type	22	NMOD	I-cell_type
O	O	371	377	artery	artery	I-NP	NN	I-cell_type	22	NMOD	I-cell_type
O	O	378	389	endothelial	endothelial	I-NP	JJ	I-cell_type	22	NMOD	I-cell_type
O	O	390	395	cells	cell	I-NP	NNS	I-cell_type	17	OBJ	I-cell_type
O	O	396	400	from	from	B-PP	IN	O	17	VMOD	O
O	O	401	408	oxidant	oxidant	B-NP	JJ	O	25	NMOD	O
O	O	409	415	injury	injury	I-NP	NN	O	23	PMOD	O
O	O	416	423	induced	induce	B-VP	VBN	O	25	NMOD	O
O	O	424	426	by	by	B-PP	IN	O	26	VMOD	O
O	O	427	435	hydrogen	hydrogen	B-NP	NN	O	29	NMOD	O
O	O	436	444	peroxide	peroxide	I-NP	NN	O	27	PMOD	O
O	O	445	446	(	(	O	(	O	32	DEP	O
O	O	446	450	H2O2	H2O2	B-NP	NN	O	32	DEP	O
O	O	450	451	)	)	O	)	O	29	NMOD	O
O	O	451	452	.	.	O	.	O	3	P	O

O	O	453	455	In	In	B-PP	IN	O	5	VMOD	O
O	O	456	460	this	this	B-NP	DT	O	3	NMOD	O
O	O	461	466	study	study	I-NP	NN	O	1	PMOD	O
O	O	467	469	we	we	B-NP	PRP	O	5	SUB	O
O	O	470	480	determined	determine	B-VP	VBD	O	0	ROOT	O
O	O	481	484	the	the	B-NP	DT	O	7	NMOD	O
O	O	485	492	effects	effect	I-NP	NNS	O	5	OBJ	O
O	O	493	495	of	of	B-PP	IN	O	7	NMOD	O
T12	B-Entity	496	499	SAC	SAC	B-NP	NN	O	8	PMOD	O
O	O	500	502	on	on	B-PP	IN	O	7	NMOD	O
T13	B-Entity	503	505	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T13	I-Entity	505	506	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T13	I-Entity	506	511	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T13	I-Entity	512	513	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	514	524	activation	activation	I-NP	NN	O	10	PMOD	O
O	O	525	527	in	in	B-PP	IN	O	15	NMOD	O
O	O	528	533	human	human	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	534	535	T	T	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	536	547	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	548	549	(	(	O	(	O	23	DEP	O
O	O	549	555	Jurkat	Jurkat	B-NP	NN	B-cell_line	22	NMOD	B-cell_line
O	O	556	561	cells	cell	I-NP	NNS	I-cell_line	23	DEP	I-cell_line
O	O	561	562	)	)	O	)	O	19	NMOD	O
O	O	563	570	induced	induce	B-VP	VBN	O	15	NMOD	O
O	O	571	573	by	by	B-PP	IN	O	24	VMOD	O
T1	B-Protein	574	579	tumor	tumor	B-NP	NN	B-protein	29	NMOD	B-protein
T1	I-Protein	580	588	necrosis	necrosis	I-NP	NN	I-protein	29	NMOD	I-protein
T1	I-Protein	589	595	factor	factor	I-NP	NN	I-protein	29	NMOD	I-protein
T1	I-Protein	596	601	alpha	alpha	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	602	603	(	(	O	(	O	34	DEP	O
T2	B-Protein	603	606	TNF	TNF	B-NP	NN	B-protein	33	NMOD	B-protein
T2	I-Protein	606	607	-	-	O	HYPH	I-protein	33	P	I-protein
T2	I-Protein	608	613	alpha	alpha	B-NP	SYM	I-protein	34	DEP	I-protein
O	O	613	614	)	)	O	)	O	29	NMOD	O
O	O	615	618	and	and	O	CC	O	36	NMOD	O
O	O	619	623	H2O2	H2O2	B-NP	NN	O	25	PMOD	O
O	O	623	624	.	.	O	.	O	5	P	O

O	O	625	634	Activated	Activate	B-NP	VBN	O	5	NMOD	O
T14	B-Entity	635	637	NF	NF	I-NP	NN	B-protein	5	NMOD	B-protein
T14	I-Entity	637	638	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T14	I-Entity	638	643	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T14	I-Entity	644	645	B	B	I-NP	NN	I-protein	9	SUB	I-protein
O	O	646	648	in	in	B-PP	IN	O	5	NMOD	O
O	O	649	656	nuclear	nuclear	B-NP	JJ	O	8	NMOD	O
O	O	657	665	extracts	extract	I-NP	NNS	O	6	PMOD	O
O	O	666	669	was	be	B-VP	VBD	O	0	ROOT	O
O	O	670	678	measured	measure	I-VP	VBN	O	9	VC	O
O	O	679	681	by	by	B-PP	IN	O	10	VMOD	O
O	O	682	684	an	an	B-NP	DT	O	16	NMOD	O
O	O	685	700	electrophoretic	electrophoretic	I-NP	JJ	O	16	NMOD	O
O	O	701	709	mobility	mobility	I-NP	NN	O	16	NMOD	O
O	O	710	715	shift	shift	I-NP	NN	O	16	NMOD	O
O	O	716	721	assay	assay	I-NP	NN	O	11	PMOD	O
O	O	722	727	using	use	B-VP	VBG	O	16	NMOD	O
O	O	728	731	32P	32P	B-NP	NN	B-DNA	21	NMOD	B-DNA
O	O	731	732	-	-	O	HYPH	I-DNA	21	NMOD	I-DNA
O	O	732	739	labeled	label	B-NP	VBN	I-DNA	21	NMOD	I-DNA
O	O	740	745	probe	probe	I-NP	NN	I-DNA	17	OBJ	I-DNA
O	O	745	746	.	.	O	.	O	9	P	O

T15	B-Entity	747	750	SAC	SAC	B-NP	NN	O	3	SUB	O
O	O	751	763	consistently	consistently	B-ADVP	RB	O	3	VMOD	O
O	O	764	773	exhibited	exhibit	B-VP	VBD	O	0	ROOT	O
O	O	774	775	a	a	B-NP	DT	O	5	NMOD	O
O	O	776	780	dose	dose	I-NP	NN	O	8	NMOD	O
O	O	780	781	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	781	790	dependent	dependent	I-NP	JJ	O	8	NMOD	O
O	O	791	801	inhibition	inhibition	I-NP	NN	O	3	OBJ	O
O	O	802	804	of	of	B-PP	IN	O	8	NMOD	O
T16	B-Entity	805	807	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T16	I-Entity	807	808	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T16	I-Entity	808	813	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T16	I-Entity	814	815	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	816	826	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	827	834	induced	induce	B-VP	VBN	O	14	NMOD	O
O	O	835	837	by	by	B-PP	IN	O	15	VMOD	O
O	O	838	842	both	both	O	CC	O	22	NMOD	O
T3	B-Protein	843	846	TNF	TNF	B-NP	NN	B-protein	20	NMOD	B-protein
T3	I-Protein	846	847	-	-	O	HYPH	O	20	P	O
T3	I-Protein	847	852	alpha	alpha	B-NP	SYM	O	22	NMOD	O
O	O	853	856	and	and	O	CC	O	22	NMOD	O
O	O	857	861	H2O2	H2O2	B-NP	NN	O	16	PMOD	O
O	O	861	862	.	.	O	.	O	3	P	O

O	O	863	873	Supershift	Supershift	B-NP	NN	O	11	SUB	O
O	O	874	878	with	with	B-PP	IN	O	1	NMOD	O
O	O	879	887	specific	specific	B-NP	JJ	B-protein	4	NMOD	B-protein
O	O	888	898	antibodies	antibody	I-NP	NNS	I-protein	2	PMOD	I-protein
O	O	899	901	to	to	B-PP	TO	O	4	NMOD	O
O	O	902	904	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	904	905	-	-	I-NP	HYPH	I-protein	10	NMOD	I-protein
O	O	905	910	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	911	912	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	913	921	subunits	subunit	I-NP	NNS	I-protein	5	PMOD	I-protein
O	O	922	931	confirmed	confirm	B-VP	VBD	O	0	ROOT	O
O	O	932	936	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	937	940	the	the	B-NP	DT	O	16	NMOD	O
O	O	941	950	inducible	inducible	I-NP	JJ	O	16	NMOD	O
O	O	951	959	retarded	retard	I-NP	VBN	O	16	NMOD	O
O	O	960	965	bands	band	I-NP	NNS	O	12	SBAR	O
O	O	966	974	observed	observe	B-VP	VBN	O	16	NMOD	O
O	O	975	977	in	in	B-PP	IN	O	17	VMOD	O
O	O	978	981	the	the	B-NP	DT	O	25	NMOD	O
O	O	982	986	EMSA	EMSA	I-NP	NN	O	25	NMOD	O
O	O	987	990	and	and	I-NP	CC	O	25	NMOD	O
T4	B-Protein	991	994	p65	p65	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	994	995	-	-	B-NP	HYPH	O	25	NMOD	O
T5	B-Protein	995	998	p50	p50	I-NP	NN	B-protein	25	NMOD	B-protein
T17	B-Entity	999	1010	heterodimer	heterodimer	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	1011	1013	of	of	B-PP	IN	O	25	NMOD	O
O	O	1014	1017	the	the	B-NP	DT	O	34	NMOD	O
T18	B-Entity	1018	1020	NF	NF	I-NP	NN	B-protein	34	NMOD	B-protein
T18	I-Entity	1020	1021	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T18	I-Entity	1021	1026	kappa	kappa	I-NP	NN	I-protein	34	NMOD	I-protein
T18	I-Entity	1027	1028	B	B	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	1028	1029	/	/	B-VP	SYM	I-protein	34	NMOD	I-protein
O	O	1029	1032	Rel	Rel	B-NP	NN	I-protein	34	NMOD	I-protein
O	O	1033	1040	protein	protein	I-NP	NN	I-protein	26	PMOD	I-protein
O	O	1040	1041	.	.	O	.	O	11	P	O

O	O	1042	1045	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	1046	1050	data	datum	I-NP	NNS	O	3	SUB	O
O	O	1051	1058	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1059	1063	that	that	B-SBAR	IN	O	3	VMOD	O
T19	B-Entity	1064	1067	SAC	SAC	B-NP	NN	B-protein	6	SUB	B-protein
O	O	1068	1071	may	may	B-VP	MD	O	4	SBAR	O
O	O	1072	1075	act	act	I-VP	VB	O	6	VC	O
O	O	1076	1079	via	via	B-PP	IN	O	7	VMOD	O
O	O	1080	1091	antioxidant	antioxidant	B-NP	JJ	O	10	NMOD	O
O	O	1092	1102	mechanisms	mechanism	I-NP	NNS	O	8	PMOD	O
O	O	1103	1105	to	to	B-VP	TO	O	12	VMOD	O
O	O	1106	1111	block	block	I-VP	VB	O	6	VMOD	O
T20	B-Entity	1112	1114	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T20	I-Entity	1114	1115	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T20	I-Entity	1115	1120	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T20	I-Entity	1121	1122	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	1123	1133	activation	activation	I-NP	NN	O	12	OBJ	O
O	O	1134	1136	in	in	B-PP	IN	O	17	NMOD	O
O	O	1137	1143	Jurkat	Jurkat	B-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	1144	1149	cells	cell	I-NP	NNS	I-cell_line	18	PMOD	I-cell_line
O	O	1149	1150	.	.	O	.	O	3	P	O
